Modelling the Effects of Paclitaxel and Cisplatin on Breast and Ovarian Cancer

Journal of Theoretical Medicine
doi 10.1080/10273660008833061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Synergistic Anti-Neoplastic Effect of AG1478 in Combination With Cisplatin or Paclitaxel on Human Endometrial and Ovarian Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2010English

Telodendrimer Nanocarrier for Co-Delivery of Paclitaxel and Cisplatin: A Synergistic Combination Nanotherapy for Ovarian Cancer Treatment

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2015English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

The Genetics of Breast and Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1995English

Clinical Trials and Progress With Paclitaxel in Ovarian Cancer

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2010English

Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Effect of Paclitaxel Loaded Chitosan Nanoparticles and Quantum Dots on Breast Cancer

Proceedings
2017English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy